Right to Try for Individualized Treatments Act

This bill, known as the Right to Try for Individualized Treatments Act, allows patients with life-threatening diseases or severe illnesses to access certain experimental drugs tailored to their specific genetic makeup without going through the standard FDA approval process. To qualify, a patient must have exhausted approved treatment options and receive a written recommendation from a doctor who is not paid by the drug manufacturer. The law permits manufacturers and eligible healthcare facilities to offer these personalized treatments if the patient provides informed consent and the facility operates under existing federal safety regulations. Importantly, the bill does not require manufacturers to provide these treatments, leaving the decision to share them entirely up to the companies involved.